Skip to content

Psychological treatment in the regulation of long-term hypnotic drug use

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33231235
Enrollment
209
Registered
2003-04-25
Start date
1998-08-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and behavioural disorders: Other mental disorder Mental and Behavioural Disorders

Interventions

Structured package vs standard care

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 31-92 with chronic sleep problems who had been receiving repeat prescriptions for hypnotic drugs for at least one month

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

MeasureTime frame
Main outcomes included: global sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI); frequency of life (as measured by the SF-36); NHS service costs; and overall cost utility. For statistical analysis all non-categorical outcomes were modelled as baseline minus follow-up change scores

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026